Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.

NCT00671671 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis, Chronic
Hepatitis C Virus

Interventions

DRUG: Small Molecule Agent (PF-868554)
DRUG: Small Molecule Agent (PF-868554)

Sponsor

Pfizer